Advocates of the Make America Healthy Again agenda have expressed skepticism over President Donald Trump’s agreement with ...

Even after Trump’s new deal, obesity drugs are still too expensive.

President Trump's plan drops the price of Ozempic and Wegovy for Americans, with plans for Medicare to cover the popular ...

Medicare beneficiaries will soon be able to get obesity and Type 2 diabetes drugs for a $50 copay. But there are some ...

Medicare will cover semaglutide (Wegovy) and tirzepatide (Zepbound) for their weight management indications for people with ...

For years, obesity rates in the US have gone in one direction: up. From the first year it was launched, Gallup’s National ...

Trump announced new deals with Eli Lilly and Novo Nordisk to lower GLP-1 costs for Medicare, Medicaid, and cash-paying patients.

Medicare will cover weight-loss drugs under a deal between the Trump administration and drugmakers Eli Lilly and Novo Nordisk ...

Popular GLP-1 drugs like Ozempic will get cheaper in exchange for partial Medicare coverage, opening up new markets for Eli ...

A new Gallup poll indicates that the obesity rate among U.S. adults has declined over the past three years as the number of ...

A small study helps explain why some people taking Wegovy and similar weight-loss drugs cut back on alcohol, offering insight ...

Many doctors and patients came to believe the rise in obesity may be all but biologically inescapable, despite the grave ...